Fulgent Genetics: Core Growth Re-Acceleration Will Be The Critical Catalyst

Adam Gault/OJO Images via Getty Images Fulgent Genetics, Inc., (NASDAQ:FLGT) is a leading provider of comprehensive genetic testing solutions, offering an extensive suite of testing services to healthcare providers, researchers, and individuals, mainly in the United States. The company specializes in next-generation sequencing ("NGS") technology, enabling the analysis of various genetic conditions and diseases with high accuracy and efficiency. Following the acquisition of Fulgent Pharma, the company is als ...